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Background/aim: Atrial natriuretic peptide (ANP) is known as a protective agent against ischemia-reperfusion injury for cardiomyocytes.
We compared the hemodynamic effects of ANP and isatin, which is known as an ANP receptor blocker, in ischemia followed by
reperfusion in exercised rat hearts with nonexercised ones.
Materials and methods: Isolated hearts were perfused in 4 exercised (E) groups after a running protocol for 5 days and 4 nonexercised
(NE) groups. In the first protocol, ANP was added to the perfusion solution before ischemia in an E and NE group. In the second
protocol, different doses of isatin (0.1, 10, 100 µM/L) were added to the perfusion solution before ANP in 3 E and 3 NE groups. Left
ventricular developed pressure (LVDP) and maximum and minimum rates of change in left ventricular pressure (dP/dtmax and dP/
dtmin) were recorded.
Results: Higher LVDP and dP/dtmin values were observed in the E group than the NE group following addition of ANP before ischemia.
Values of dP/dtmax were higher in the E group at the first minute of reperfusion period. Hemodynamic difference was not observed
between groups given the same amount of isatin before ANP.
Conclusion: This study indicated that higher ANP concentrations before ischemia were more effective on the left ventricle contractility
and relaxation functions in the hearts that were exposed to exercise.
Key words: Atrial natriuretic peptide, ischemia, exercise, cardiac contractility, isatin

1. Introduction
Atrial natriuretic peptide (ANP) is known as a cardiac
endocrine hormone that is essential in regulating blood
volume through its natriuretic, diuretic, and vasodilator
effects. ANP is primarily synthesized and secreted by atrial
cardiomyocytes (1). It was demonstrated that an acute
mechanical stretch of atrial wall was the most important
stimulus for synthesis and secretion of this hormone (2).
Exercise is known as a factor that increases mechanical
stretch and pressure of the atrium. Additionally, increased
plasma ANP concentrations have been observed following
exercise in healthy subjects (3–5).
Known as a cardioprotective agent, ANP is reported to
be potentially effective on acute myocardial infarction (6).
ANP generates inhibitor effects in ischemia-reperfusion
injury at the myocardium through the cyclic guanosine
monophosphate pathway (cGMP) (7). The ANP receptor/
* Correspondence: arzuvardar@trakya.edu.tr
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cGMP signaling pathway activates protein kinase G, and
thus mitochondrial K-ATP channels open and infarct sizes
in rabbit hearts are reduced (8). It has been demonstrated
that intravenous administration of ANP ameliorates left
ventricle functions in patients with acute myocardial
infarction (9). Improved left ventricular function has
been reported when ANP is administered during the
reperfusion period in isolated perfused rat hearts (10). In
addition, it has been shown that administration of ANP
in the reperfusion period restricts infarct size in rabbit
hearts (8). However, it remains unclear whether there are
any differences in cardiac hemodynamics when the heart
is exposed to the effect of both exercise and higher ANP
concentrations before ischemia.
We hypothesized in this study that ANP administration
before ischemia could improve left ventricle contractility
function in rat hearts that were exposed to exercise
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compared with hearts that were not exposed to
exercise. Thus, the aim of this study was to compare the
hemodynamic effects of ANP and isatin, which is known
as an ANP receptor blocker, in ischemia followed by
reperfusion in exercised rat hearts with nonexercised
hearts.
2. Materials and methods
2.1. Animals
Male Sprague Dawley rats (n = 47; weighing 300–450 g
and 4–6 months old) were used in this study. All animals
were housed with free access to a standard diet and tap
water, with a 12/12-h light/dark cycle, a mean temperature
of 21 ± 2 °C, and humidity of 55 ± 2%. Experimental
protocols were reviewed and approved by the local ethics
committee of Trakya University and the Animal Care and
Use Committee of the Trakya University Medical Faculty.
Animals were divided into exercised (E1, E2, E3, E4)
and nonexercised (NE1, NE2, NE3, NE4) groups. Global
ischemia (35 min) and reperfusion (30 min) were applied
in all groups (Figure 1). Two separate protocols were
used in exercised and nonexercised groups. In protocol
A, ischemia and reperfusion were applied and ANP (0.1
µM/L) was added to the perfusion solution for 15 min
before ischemia in an exercise (E1) group (n = 6) and a
nonexercise (NE1) group (n = 6). ANP concentration was
applied as 0.1 µM/L, since improved cardiac output had

been reported when this concentration in reperfusion
solution was administered in a previous study (10). After
perfusion of the heart with Krebs–Henseleit solution for 15
min, basal hemodynamic measurements (K) were obtained.
Measurements were repeated following perfusion of the
heart with Krebs–Henseleit solution including ANP at the
5th minute (ANP1) and 15th minute (ANP2), and at the 1st
(R1), 15th (R2), and 30th (R3) minute of the reperfusion
period (Figure 1). As hemodynamic measurements,
left ventricular developed pressure (LVDP), maximum
rates of change in left ventricular pressure (dP/dtmax),
minimum rates of change in left ventricular pressure (dP/
dtmin), and heart rate (HR) were continuously monitored
in this study. Therefore, the hemodynamic effects of ANP
before ischemia in exercised and nonexercised hearts were
compared. Protocol B was conducted in the second part
of the study. Before the administration of ANP, different
doses of isatin (0.1, 10, 100 µM/L) were given in the
perfusion solution of 3 exercised groups (E2, E3, E4; n =
6 in each group) and 3 nonexercised groups (NE2, NE3,
NE4; n = 6, n = 6, and n = 5, respectively). Thus, we aimed
to find out whether there were any differences among the
hemodynamic effects of ANP when applying low, modest,
or high doses of isatin before ANP. Hemodynamic values
after perfusion of K measurements following the perfusion
with Krebs–Henseleit solution including different doses of
isatin (I), ANP1, ANP2, R1, R2, and R3 measurements,
were recorded (Figure 1).

Protocol A: E1 and NE1 Groups

Protocol B: E2, E3, E4, NE2, NE3, NE4
Groups

Figure 1. Study groups are shown. E1 = Exercised group, NE1 = nonexercised group, E2 = exercised group with 0.1 µM/L isatin
administered before ANP administration, E3 = exercised group with 10 µM/L isatin administered before ANP administration, E4
= exercised group with 100 µM/L isatin administered before ANP administration, NE2 = nonexercised group with 0.1 µM/L isatin
administered before ANP administration, NE3 = nonexercised group with 10 µM/L isatin administered before ANP administration,
NE4 = nonexercised group with 100 µM/L isatin administered before ANP administration. K, baseline; ANP1, 5 min of atrial natriuretic
peptide infusion; ANP2, 15 min of atrial natriuretic peptide infusion; R1, 1 min of reperfusion; R2, 15 min of reperfusion; R3, 30 min
of reperfusion; I, measurement made after 1 min of isatin infusion.
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2.2. Exercise
A standard exercise protocol was applied in the exercised
rats similar to another study (11). Exercise groups were
exposed to a running protocol for 5 days according to
this protocol. Animals were exercised during the first
4 consecutive days on a treadmill. The duration of daily
exercise was 15 min at a speed of 15 m/min in the first
4 days. This period was accepted as moderate exercise
and also as a training period to prepare the animals for
the last day of vigorous exercise. The vigorous exercise of
the 5th day lasted 25 min at 25 m/min (11). At the end of
the vigorous exercise period, the animals were killed, their
hearts were harvested, and isolated hearts were perfused
within 1 h after the last bout of exercise.
2.3. Preparation of isolated heart
After the last bout of exercise, the rats were anesthetized
with thiopental (100 mg/kg, I.E. Ulagay A.Ş., İstanbul,
Turkey). Heparin was injected (500 IU/kg; Nevparin
Flakon, Mustafa Nevzat İlaç Sanayi A.Ş., İstanbul, Turkey)
prior to anesthesia. Both of the drugs were administered
intraperitoneally. After onset of anesthesia, the hearts were
rapidly excised, immersed into ice-cold Krebs–Henseleit
solution, and attached to the Langendorff apparatus. The
hearts were cannulated from the aorta and retrogradely
perfused with oxygenated Krebs–Henseleit solution
containing NaCl at 118.3 mmol L–1, NaHCO3 25.0 mmol
L–1, KCl 4.7 mmol L–1, KH2PO4 1.2 mmol L–1, MgSO4 1.2
mmol L–1, CaCl2 2.5 mmol L–1, and glucose 11.1 mmol L–1.
The perfusate was equilibrated with 95% O2 and 5% CO2,
maintained at 37 °C and pH 7.4 for 15 min in each group
at a constant pressure of 65–70 mmHg. A water-filled latex
balloon was placed in the left ventricle through the mitral
valve. LVDP, dP/dtmax, dP/dtmin, and HR were continuously
monitored by a data acquisition system (BIOPAC MP36
System, Inc., USA) during the experiments.
Catheterization to the left ventricle was applied to
obtain LVDP, dP/dtmax, and dP/dtmin levels in this study.
LVDP was estimated by subtracting the end-diastolic
pressure from the systolic pressure. As the components to
generate dP/dt, P shows LV pressure, t shows time, and
d shows rate of change. It is accepted that dP/dtmax gives
valuable knowledge about the inotropic features of the left
ventricle; therefore, it is also called the inotropic index
(12).
2.4. Statistical analysis
Statistical analyses were carried out using SPSS 20.0
(License No. 10240642). All values were expressed as
median (interquartile range). Hemodynamic variables
and intragroup changes of hemodynamic variables were
compared by Mann–Whitney U test in 2 groups. P < 0.05
was considered statistically significant.
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3. Results
For protocol A, when the measurements obtained for K,
ANP1, ANP2, R1, R2, and R3 were compared between the
E1 and NE1 groups, a significant difference was observed
in ANP2 for LVDP values (P = 0.045, Table 1). Higher
LVDP was shown in the E1 group. Values of dP/dtmax
were compared in the E1 and NE1 groups and higher dP/
dtmax levels were found in R1 of the E1 group (P = 0.028).
When dP/dtmin values in the two groups were compared,
significantly different values were shown in ANP1 and
ANP2 between the E1 and NE1 groups (respectively P
= 0.045 and P = 0.045). dP/dtmin values in the E1 group
were found to be more negative, which showed higher
relaxation, than in the NE1 group (Table 1). When the
alterations of heart rate data in the E1 and NE1 groups
were compared, no difference was found in heart rate
values between E1 and NE1 groups (Table 2).
Changes from K to ANP1, ANP2, R1, R2, and R3 for
hemodynamic measurements were also compared between
the E1 and NE1 groups. It was found that changes in LVDP
from K to ANP2 in the E1 group were significantly higher
than in the NE1 group (P = 0.045, Figure 2). No difference
was found when changes from K to ANP1, ANP2, R1,
R2, and R3 for dP/dtmax values were compared between
the E1 and NE1 groups. It was seen that changes from K
to ANP1 and ANP2 for dP/dtmin values in the E1 group
were significantly decreased while they were significantly
increased in the NE1 group (Table 3).
For protocol B, hemodynamic effects of the 3
different doses of isatin that were administered before
ANP in exercised and nonexercised isolated hearts were
investigated. When the LVDP, dP/dtmax, and dP/dtmin
values were compared between the E2 and NE2 groups,
which were administered 0.1 µM/L isatin, they were not
found to be significantly different in K, I, ANP-1, ANP-2,
R1, R2, and R3 measurements (Table 4).
When the values were compared for LVDP, dP/dtmax,
and dP/dtmin between the E3 and NE3 groups, no significant
difference was seen in hemodynamic measurements.
However, when compared for the E4 and NE4 groups,
higher LVDP values were shown in R3 of the NE4 group
(P = 0.014). Values of dP/dtmax and dP/dtmin between the E4
and NE4 groups were not significantly different. Heart rate
values did not differ between the E2 and NE2 groups, the
E3 and NE3 groups, and the E4 and NE4 groups.
Changes from K to I, ANP1, ANP2, R1, R2, and R3
for hemodynamic values were compared between the E2
and NE2, the E3 and NE3, and the E4 and NE4 groups.
No difference was seen when the changes were compared
for K to I, ANP1, ANP2, R1, R2, and R3 for LVDP, dP/
dtmax, and dP/dtmin values between the E2 and NE2 groups.
Similarly, hemodynamic values between the E3 and NE3
groups and the E4 and NE4 groups were not found to be
significantly different (P > 0.05 for all comparisons).
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Table 1. Hemodynamic data of E1 and NE1 groups. Values are expressed as median (interquartile). E1 = Exercised group, NE1 =
nonexercised group, K = baseline measurement, ANP1 = measurement made after 5 min of atrial natriuretic peptide administration,
ANP2 = measurement made after 15 min of atrial natriuretic peptide administration, R1 = measurement made after 1 min of reperfusion
period, R2 = measurement made after 15 min of reperfusion period, R3 = measurement made after 30 min of reperfusion period, LVDP
= left ventricular developed pressure, dP/dtmax = maximum rate of change in left ventricular pressure, dP/dtmin = minimum rate of change
in left ventricular pressure.

K

ANP1

ANP2

R1

R2

R3

E1 (n = 6)

NE1 (n = 6)

P

LVDP

69 (34)

68 (21)

0.465

dP/dtmax

1213 (1265)

1250 (551)

0.584

dP/dtmin

−1247 (826)

−1211 (182)

0.584

LVDP

83 (54)

62 (25)

0.100

dP/dtmax

1111 (2314)

1012 (914)

0.584

dP/dtmin

−1462 (965)

−1074 (251)

0.045

LVDP

84 (73)

52 (46)

0.045

dP/dtmax

1499 (1722)

1068 (1531)

0.144

dP/dtmin

−1356 (1119)

−904 (575)

0.045

LVDP

83 (104)

1.7 (22)

0.273

dP/dtmax

109 (1181)

−452 (409)

0.028

dP/dtmin

−334 (840)

−595 (395)

0.465

LVDP

0.6 (41)

0.2 (12)

0.647

dP/dtmax

34 (896)

−346 (263)

0.100

dP/dtmin

−153 (843)

−443 (241)

0.144

LVDP

2 (40)

0.2 (18)

0.917

dP/dtmax

−52 (1228)

−150 (358)

0.327

dP/dtmin

−236 (776)

−397 (561)

0.602

Table 2. Heart rate values of E1 and NE1 groups. Values are expressed as median
(interquartile). E1 = Exercised group, NE1 = nonexercised group, K = baseline
measurement, ANP1 = measurement made after 5 min of atrial natriuretic peptide
administration, ANP2 = measurement made after 15 min of atrial natriuretic peptide
administration, R1 = measurement made after 1 min of reperfusion period, R2 =
measurement made after 15 min of reperfusion period, R3 = measurement made after
30 min of reperfusion period.
E1 (n = 6)

NE1 (n = 6)

P

K

236 (48)

249 (36)

0.927

ANP1

222 (58)

220 (84)

0.465

ANP2

211 (50)

222 (71)

0.584

R1

166 (159)

273 (195)

0.144

R2

248 (165)

225 (85)

0.584

R3

366 (179)

286 (129)

0.347
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Figure 2. Left ventricular developed pressures in NE1 and E1 groups. *: P < 0.05 when differences of left ventricular developed pressure
changes from K to ANP2 are compared between NE1 and E1 groups. E1 = Exercised group, NE1 = nonexercised group, K = baseline
measurement, ANP1 = measurement made after 5 min of atrial natriuretic peptide administration, ANP2 = measurement made after 15
min of atrial natriuretic peptide administration, R1 = measurement made after 1 min of reperfusion period, R2 = measurement made
after 15 min of reperfusion period, R3 = measurement made after 30 min of reperfusion period.
Table 3. Changes from K to ANP1, ANP2, R1, R2 and R3 of dP/dtmax and dP/dtmax measurements
in E1 and NE1 groups. Values are expressed as median (interquartile). E1 = Exercised group,
NE1 = nonexercised group, ∆K-ANP1 = changes from K to ANP1, ∆K-ANP2 = changes from K to ANP2,
∆K-R1 = changes from K to R1, ∆K-R2 = changes from K to R2, ∆K-R3 = changes from K to R3.

dP/dtmax

dP/dtmin

E1 (n = 6)

NE1 (n = 6)

∆K-ANP1

–79 (–1461)

15 (–724)

0.361

∆K-ANP2

–286 (–804)

128 (–1599)

0.100

∆K-R1

946 (–2293)

1875 (–654)

0.361

∆K-R2

989 (–1697)

1684 (–539)

0.584

∆K-R3

951 (–1360)

1618 (–670)

0.221

∆K-ANP1

215 (–966)

−172 (–251)

0.045

∆K-ANP2

109 (–1119)

−343 (–575)

0.045

∆K-R1

−912 (–840)

−651 (–395)

0.465

∆K-R2

−1093 (–734)

−803 (–240)

0.144

∆K-R3

−1011 (–776)

−849 (–561)

0.602

The body weights of exercised rats (n = 18) were
compared before and after exercise in this study. A
signiﬁcant decrease was observed in the body weight after
exercise (347 (75) g) when compared before exercise (351
(64) g) in this running model (P = 0.001).
4. Discussion
The results of this study demonstrated that LVDP, which
shows the contractility function of the left ventricle,
was higher after the addition of ANP into the perfusion
solution in isolated hearts that were exposed to exercise
compared with the hearts not exposed to exercise. Higher
ANP concentrations before global ischemia caused more
effective alterations in dP/dtmin values, which represent a
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P

relaxation function of the left ventricle, in exercised hearts.
Additionally, the values of dP/dtmax that were measured
following global ischemia were found to be higher in
exercised hearts than nonexercised hearts in the first
minute of the reperfusion period. When the same amount
of isatin was administered for blocking of ANP receptors,
however, no difference was found in hemodynamic values
between groups.
Plasma ANP concentration increases following physical
exercise in healthy subjects (3–5). Additionally, higher
plasma ANP levels have been observed in athletes compared
with healthy controls (13). It was reported in another study
that plasma ANP concentrations were found higher in
the resting position in archery athletes in comparison to
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Table 4. Left ventricular developed pressure, dP/dtmax, and dP/dtmin values of E2, NE2, E3, NE3, E4, and NE4 groups. Values are expressed
as median (interquartile). E2 = Exercises group with 0.1 µM/L isatin administered before ANP administration, E3 = exercised group
with 10 µM/L isatin administered before ANP administration, E4 = exercised group with 100 µM/L isatin administered before ANP
administration, NE2 = nonexercised group with 0.1 µM/L isatin administered before ANP administration, NE3 = nonexercised group
with 10 µM/L isatin administered before ANP administration, NE4 = nonexercised group with 100 µM/L isatin administered before
ANP administration, K = baseline measurement, I = measurement made after 1 min of isatin administration, ANP1 = measurement
made after 5 min of atrial natriuretic peptide administration, ANP2 = measurement made after 15 min of atrial natriuretic peptide
administration, R1 = measurement made after 1 min of reperfusion period, R2 = measurement made after 15 min of reperfusion period,
R3 = measurement made after 30 min of reperfusion period, LVDP = left ventricular developed pressure, dP/dtmax = maximum rate of
change in left ventricular pressure, dP/dtmin = minimum rate of change in left ventricular pressure.

K

I

ANP1

ANP2

R1

R2

R3

E2 (n = 6)

NE2 (n = 6)

P

E3 (n = 6)

NE3 (n = 6)

P

E4 (n = 6)

NE4 (n = 5)

P

LVDP

92 (38)

88 (28)

0.873

94 (27)

82 (20)

0.572

85 (43)

85 (57)

0.221

dP/dtmax

1601 (1321)

1930 (690)

0.715

1991 (1333)

1671 (611)

0.100

1620 (775)

1525 (1625)

0.670

dP/dtmin

–1650 (789)

–1524 (668)

0.273

–1831 (715)

–1330 (1482)

0.078

–1634 (755)

–1187 (632)

0.055

LVDP

82 (47)

92 (40)

0.470

93 (48)

91 (31)

0.147

83 (45)

62 (104)

0.219

dP/dtmax

1660 (1645)

2095 (549)

0.175

2209 (2790)

1459 (814)

0.273

1770 (1125)

970 (2118)

0.286

dP/dtmin

–1705 (1209)

–1603 (910)

1.000

–1749 (1098)

–1110 (1258)

0.200

–1667 (609)

–857 (1913)

0.201

LVDP

82 (59)

81 (37)

0.296

57 (66)

76 (100)

0.575

78 (39)

61 (76)

0.086

dP/dtmax

1609 (2316)

1725 (407)

0.465

1616 (3127)

1062 (2944)

0.337

1754 (1102)

947 (1992)

0.522

dP/dtmin

–1648 (1598)

–1436 (1078)

0.602

–513 (1705)

–759 (1635)

0.337

–1424 (859)

–808 (1277)

0.201

LVDP

85 (82)

78 (46)

0.314

40 (72)

53 (94)

0.936

66 (82)

54 (75)

0.624

dP/dtmax

1425 (2257)

1728 (723)

0.465

954 (2867)

715 (2599)

0.522

1495 (1550)

799 (1994)

0.624

dP/dtmin

–1403 (1424)

–1388 (784)

0.855

–580 (1300)

–740 (1291)

0.262

–883 (1127)

–775 (960)

0.327

LVDP

16 (18)

7 (25)

0.273

1 (2)

0 (2)

0.748

1 (70)

6 (59)

0.327

dP/dtmax

–437 (381)

–187 (887)

0.175

–349 (305)

–366 (1387)

0.749

–198 (794)

–140 (1522)

0.670

dP/dtmin

–668 (444)

–339 (389)

0.201

–389 (335)

–568 (641)

0.522

–396 (921)

–482 (772)

0.831

LVDP

8 (10)

13 (46)

0.464

1 (3)

0 (3)

0.297

1 (48)

8 (26)

0.176

dP/dtmax

–291 (219)

576 (1333)

0.117

–288 (252)

–378 (565)

0.749

–291 (659)

–56 (684)

0.522

dP/dtmin

–484 (381)

–540 (626)

0.584

–442 (390)

–482 (218)

0.749

–345 (679)

–508 (534)

0.670

LVDP

8 (16)

29 (56)

0.273

1 (5)

1 (9)

0.470

1 (48)

14 (27)

0.014

dP/dtmax

–74 (236)

594 (1509)

0.175

–227 (258)

–323 (711)

1.000

–227 (580)

13 (770)

0.394

dP/dtmin

–469 (355)

–765 (936)

0.361

–355 (395)

–417 (167)

0.522

–296 (708)

–569 (567)

0.831

untrained healthy controls (14). It was shown that an increase
in plasma ANP concentrations in healthy subjects may
eliminate intermittent overhydration and may participate
in the regulation of diuresis and natriuresis resulting
from postural changes (6). On the other hand, studies
demonstrated that plasma ANP concentration increases
following myocardial diseases (7). Elevated natriuretic
peptides may cause antiischemic effects on the heart (8).
It was shown in an isolated heart study that preischemic
infusion of a synthetic alpha-human ANP agent exerted
cardioprotective effects through mitochondrial K-ATP

channel activation (9). Additionally, increase in plasma ANP
concentration can play a role in improving left ventricle
contractility function via its autocrine/paracrine actions
(10), or in affecting cardiocirculatory hemodynamics,
including endocrine and renal functions, lipid metabolism,
and the pump function of the heart (15). It was shown in a
past study that, when administered to male subjects, ANP
improved myocardial diastolic function and increased
myocardial relaxation depending on the dose used (16).
Therefore, an ischemic model was generated in the present
study to compare the hemodynamic effects of ANP, which
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was applied before ischemia. It was seen in this study that
no hemodynamic difference was shown in the exercised
(E1) and nonexercised (E2) groups before administration
of ANP. However, differences were observed in LVDP, dP/
dtmin, and dP/dtmax values after administration of ANP.
These findings demonstrated that higher concentrations
of ANP before ischemia may have beneficial effects on the
contractility and relaxation function of hearts exposed to
exercise.
When considering the effects of ANP on the
reperfusion period, significant increases in dP/dtmax values
were found in the exercised group only in the first minute
of reperfusion. Hemodynamic alterations for LVDP or
dP/dtmin values following ANP administration were not
observed in the reperfusion period. This finding may result
from the fact that administration of ANP in reperfusion
solution did not proceed during the reperfusion period.
The supply of oxygenated perfusion fluid to the
myocardium was suspended for 35 min in this global
ischemic model. This resulted in obvious hemodynamic
changes such as negative dP/dtmax values in the reperfusion
period in the present study. It has been demonstrated
that myocardial ischemia could induce a series of cellular
signals, including an increase in Ca+2, intracellular acidosis,
accumulation of inorganic phosphates, accumulation of
lactate, and stimulation of glycolytic flux (3–5). Inorganic
phosphates have been suggested as an important reason
for the contractile failure in myocardial ischemia (17). The
total ATP content of myocardial tissue drops by 51% and
ATP concentration in the cytosol decreases by 36% at 30
min of ischemia (6). The present study demonstrated that
the harmful effects of long-term global ischemia on left
ventricle contractility were too great to be prevented by the
possible antiischemic effects arising from exercise. When
considering the different levels of ischemic conditions in
humans, the possible effects of ANP in low-flow ischemia,
rather than global ischemia, could be investigated in
further studies.
Short-term exercise training can produce some changes
in factors affecting cell function in skeletal or cardiac
muscles. It was shown that short-term exercise induces
capillary angiogenesis and muscle hypertrophy in skeletal
muscle. Additionally, remarkable effects on contractility
function of the heart muscle have been observed. Vascular
endothelial growth factor, transforming growth factor,
and basic fibroblast growth factor have been found to have
increased after 5 days of treadmill exercise in the skeletal
muscles of rats (18). Another study demonstrated that even
a single bout of exercise induced increases in mRNA levels
of some angiogenic growth factors, including vascular
endothelial growth factor, basic fibroblast growth factor,
and transforming growth factor-beta 1 in skeletal muscle.
Looking at the cardiac muscles, it has been indicated that
3 or 5 consecutive days of treadmill exercise improves
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myocardial contractility via increased myocardial left
ventricular heat shock protein 72, glutathione, and
manganese superoxide dismutase activities during
ischemia and reperfusion (19). Increasing Ca+2 sensitivity
has also been shown as a part of the mechanism involved
in training-induced improvements in the contractility
function of the myocardium (20). Coronary vascular
resistance has been accepted as the other remarkable
factor that regulates cardiac responses to exercise (21).
Five consecutive days of an exercise training program
that is known as short-term and moderate exercise were
applied in this study. The duration time was accepted as
adequate to observe the changes in the contractility of the
left ventricle in rats. However, no difference was observed
in basal hemodynamic measurements between the 2
groups when these duration and intensity levels of exercise
were applied.
Considerable difference in dP/dtmin values of ANP-1
and ANP-2 were shown in the E1 and NE1 groups in the
present study after the addition of ANP to the perfusion
solution. The rate of ventricular relaxation was shown as
dP/dtmin, which is a functional parameter seen in the early
phase of diastole (12). Ventricular relaxation is affected
by some cellular factors, including phosphorylation
of phospholamban for the uptake of calcium into the
sarcoplasmic reticulum and viscoelastic features of
myocardium. The results of this study revealed that ANP
may be effective in exercised hearts in terms of ventricular
relaxation in comparison to the nonexercised group.
Isatin is known as an endogenous indole and ANP
antagonist (22). The antagonistic effect of isatin leads to
the inhibition of guanylate cyclase and, therefore, cGMP
is decreased. Isatin has not been reported to result in the
alteration of infarct size following ischemia, but it has
been demonstrated that isatin could prevent the protective
effects of ANP on the heart (23). Interestingly, we did not
find any difference in cardiac contractility and relaxation
function when different doses of isatin were applied before
ANP in exercised and nonexercised hearts. Although isatin
has been known to play an antagonist role on natriuretic
peptide receptors, no significant change was shown
when perfused isatin by itself was administered before
ischemia in the present study. Further studies in which
ANP is administered together with isatin are needed to
understand the role of isatin on ischemia and reperfusion.
This study was unable to determine the infarct size of
the rat heart following ischemia. However, it was observed
in another study that the infarcted area was approximately
40% of the rat heart following 20 min of global ischemia
and 3 h of reperfusion (11). We applied 35 min of global
ischemia and 30 min of reperfusion to the isolated rat
hearts in this study, similar to other studies (24,25). The
duration of ischemia was accepted as sufficient to create a
considerable amount of myocardial infarct area.

VARDAR et al. / Turk J Med Sci
In summary, this study indicated that increased
ANP concentration may cause better contractility and
relaxation function of the left ventricle when rast are
exposed to short-term and moderate exercise. In the
case of exposure to exercise, higher concentrations of
ANP before ischemia may generate a remarkable effect
of cardiac contractility function in the first minutes of the

reperfusion period. However, different doses of isatin did
not seem to be effective on hemodynamic parameters in
the present study.
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